United States · FDA National Drug Code directory
Cefprozil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-034_2288a04a-b86b-4c3b-8e12-e61531cf5b43
- Product NDC
- 57237-034
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cefprozil
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070130
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFPROZIL — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (57237-034-01) · 57237-034-01
- 50 mL in 1 BOTTLE (57237-034-50) · 57237-034-50
- 75 mL in 1 BOTTLE (57237-034-75) · 57237-034-75
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →